SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

DASH is trending as discussions around privacy coins and comparisons to ZEC intensify, with traders speculating on potential gains. Community members are actively debating its future performance and whether it will follow a similar trajectory to other cryptocurrencies. Conversations also highlight DASH's limited supply and potential for significant price appreciation during the next bull run.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

KPTI is trending due to concerns around the company's leadership and financial management. Community discussions focus on the performance of the CEO, potential mismanagement, and the need for strategic changes. Upcoming phase 3 results are a key factor for the company's future, amid discussions about its cash runway and potential need for further financing.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending amidst discussions about its underlying technology and potential for growth, with some community members highlighting its long-term vision to decentralize the internet and challenge established cloud providers. Bullish sentiment centers on its strong technology, recent launch of Caffeine AI, and staking rewards, while bears cite concerns about its historical performance, tokenomics, and adoption rates. Speculation about increased volume, potential partnerships, and integration of Bitcoin DeFi are also circulating within the community.

Caesars Entertainment, Inc. engages in the management of casinos and resorts under the Caesars, Harrah's, Horseshoe, and Eldorado brands. It operates through the following segments: Las Vegas, Regional, Caesars Digital, Managed and Branded, and Corporate and Other. The company was founded in 1937 and is headquartered in Reno, NV.

Caesars Entertainment Inc

CZR is trending as investors digest recent earnings results and debate the company's future prospects, particularly its debt load and growth strategy in a competitive market. Community discussions revolve around the impact of tariffs, potential for a recession, and the attractiveness of the stock's valuation relative to its digital assets and real estate. Some traders are closely watching for a potential bottom and possible actions from activist investors like Carl Icahn.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

DXCM is trending downwards amidst concerns regarding the accuracy and reliability of its G7 continuous glucose monitor, highlighted in a recent short report. The community is discussing the potential impact of these issues on Dexcom's market share and the possibility of a class action lawsuit. Some traders believe the stock is oversold and presents a buying opportunity, while others are wary of negative sentiment and potential for further decline.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot (DOT) is trending amid mixed sentiments, with some traders eyeing potential gains from staking and anticipating a broader altcoin rally, while others express frustration with the project's performance and leadership. Discussions include potential catalysts such as ETF approvals and interoperability solutions, alongside debates about its long-term viability and tokenomics. Community members are actively weighing the risks and opportunities surrounding DOT within the current market cycle.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

ZVRA is trending as rumors of potential acquisition swirl, with the community buzzing about a potential buyout after reports of a failed financing attempt from a smaller company.  Enthusiasm is building for the upcoming earnings report and the potential for a positive outcome, while some investors express skepticism toward management. Bullish sentiment is further fueled by high short interest, leading to speculation about a possible short squeeze.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

ZS is trending as investors discuss its growth potential in the cybersecurity sector, particularly its zero-trust architecture and AI-driven security solutions. Bullish sentiment is fueled by analyst upgrades and long-term compounding growth prospects. However, some express concerns about its high valuation and upcoming earnings.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

HTZ is trending due to a partnership with Amazon to sell used cars online, sparking discussions about its potential to challenge competitors like Carvana and boost retail visibility. The community is analyzing the potential for a short squeeze, fueled by high short interest and Ackman's involvement, while also considering the company's debt and upcoming earnings.

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Biomarin Pharmaceutical Inc. - Registered Shares

Biomarin Pharmaceutical is trending as traders discuss its deep-value territory and potential for call LEAPS. The community is weighing the risk-reward ratio and catalysts, including potential news or FDA activity, with some focusing on long-term opportunities while others express bearish sentiment due to concerns about momentum and lackluster performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stem, Inc. (STEM) Reports Q3 Loss, Lags Revenue Estimates

Stem (STEM) delivered earnings and revenue surprises of -53.51% and -6.97%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Stem Announces Third Quarter 2025 Results

Stem, Inc. (Stem, we or the Company) (NYSE: STEM), a global leader reimagining technology to support the energy transition, announced today its financial results for the quarter ended Sept. 30, 2025...

CoStar Group (CSGP) Q3 Earnings and Revenues Top Estimates

CoStar (CSGP) delivered earnings and revenue surprises of +27.78% and +0.91%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Vertiv Holdings Co. (VRT) Q3 Earnings and Revenues Top Estimates

Vertiv (VRT) delivered earnings and revenue surprises of +24.00% and +3.60%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Stem Expands its European Operations as Demand Surges for Solar, Storage and Hybrid Energy Solutions

Stem, Inc. (NYSE: STEM), a global leader reimagining technology to support the energy transition, today announced the expansion of its Berlin operations with a move to centralized and collaborative...

STEM Shares Gains 12% on Narrower Q2 Loss, Revenues Increased Y/Y

STEM stock has risen nearly 12% after second-quarter revenue beat estimates, driven by strong growth in software and managed services.


Stem, Inc. (STEM) Reports Q2 Loss, Tops Revenue Estimates

Stem (STEM) delivered earnings and revenue surprises of -24.33% and +15.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Stem Gears Up to Report Q2 Earnings: What's in Store for the Stock?

STEM gears up for Q2 earnings as software momentum, cost cuts, and margin shifts drive performance trends.

Stem (STEM) Surges 45.6%: Is This an Indication of Further Gains?

Stem (STEM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Stem (STEM) Soars 8.8%: Is Further Upside Left in the Stock?

Stem, Inc. engages in the provision of an energy storage system, hardware, ongoing software platform and professional services, and solar asset performance monitoring and control. The company was founded in 2009 and is headquartered in Houston, TX.

Stem Inc - Ordinary Shares - Class A

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$2.19	--	--	N/A
Q3 '25	-$2.16	-$2.84	-31.50%	MISSED
Q2 '25	-$2.76	-$1.79	35.10%	BEAT
Q1 '25	-$0.18	-$3.00	-1537.84%	MISSED
Q4 '24	-$0.21	-$0.33	-58.46%	MISSED

STEM
Stem Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest STEM News

STEMStem Inc